induced RNA polymerase formation are inhibited in Novikoff hepatoma cells (16) . Rous sarcoma virus does not grow in the presence of actinomycin D (3, 23) , and the multiplication of reovirus (11) , influenza virus (5) , and fowl plague virus (4) is also inhibited. Newcastle disease virus is unaffected in HeLa cells (24) , but is inhibited in chick embryo monolayers (13) .
The present paper describes the effect of actinomycin D on foot-and-mouth disease virus (FMDV)-induced RNA polymerase formation in baby hamster kidney (BHK) cells and on virus production. Previous work established the existence of such a polymerase in FMDV-infected BHK cells (18) . Enzyme action in a cell-free assay was inhibited by antibody, but not by actinomycin D (18, 19) . It will be shown here that actinomycin D strongly inhibits the formation of FMDV-RNA polymerase in infected cells, but inconsistently affects the production of infectious virus in cells incubated with either growth or minimal media.
MATERIALS AND METHODS
Cells, virus, and media. BHK 21, clone 13 cells (American Type Culture Collection) were grown for 6 to 7 days in 2-liter Baxter bottles in a medium consisting of a modified Eagle's salt solution, 0.02 M tris(hydroxymethyl)aminomethane (Tris), 10% tryptose phosphate, and 10% bovine serum (20) . FMDV, type A, strain 119, passaged in calf kidney cultures 110 times, was concentrated and partially purified to an "aqueous phase" stage (2) . Two media were used in experiments: cell growth medium described previously, and a minimal medium consisting of a modified Hanks' salt solution in 1% Tris buffer containing 0.2% glucose, 0.03% glutamine, and 10% dialyzed bovine serum (17) . Cells were infected at a multiplicity of 10 plaque-forming units (PFU) per cell, and virus production was measured 5 hr postinfection (17 analysis. A 100,000 X g cytoplasmic pellet from infected cells suspended in 0.25 M sucrose-0.001 M magnesium at a protein concentration of S to 10 mg/ ml was prepared as previously described (18) . Enzymatic activity of this suspension was measured by the incorporation of tritiated uridine into acid-insoluble products (18) . RNA products from enzyme assay samples incubated in the presence of bentonite were spun through linear sucrose gradients (5 to 25%, w/v) in 0.01 M sodium acetate, pH 5.1 (1).
RESULTS
Initial experiments showed that, at a concentration of 5 ,g/ml, actinomycin D (Table 2) . Actinomycin D, present for only 15 min just prior to harvest, had no effect on polymerase production, whereas, when it was present for 2 hr before harvest, there was 46% inhibiton. Actinomycin D present from 90 min preinfection onward caused the highest inhibition, 85%.
Enzyme preparations from cells exposed to actinomycin D were studied for possible changes in their RNA products. It was first necessary to determine the effect of actinomycin D present during the polymerase assay on the nature of the RNA formed. It was known previously that actinomycin D has no effect on the amount of acidinsoluble products formed (18 The effect of actinomycin D on virus production was determined in cells incubated with cell growth and minimal media. Table 3 shows that actinomycin D, at a concentration of 5 ,ug/ml, altered virus production to a variable extent in both media. Inhibition of virus production in cells incubated with growth and minimal media ranged from 0 to 0.3 and from 0 to 0.6 log units, respectively. Increasing the exposure of cells to actinomycin D by preincubation with the antibiotic before infection did not always further decrease virus production.
It has been reported that the inhibiton of poliovirus growth by actinomycin D may be prevented by insulin (7) . Experiments were, therefore, run in the presence of 2 to 50 ,ug of insulin per ml with actinomycin D-treated, infected cells incubated in both growth and minimal media. The results showed no significant differences in actinomycin D inhibition of virus and enzyme production in the presence of insulin.
DIscussIoN
Our results have indicated that actinomycin D interferes with the kinetics and ultimate level of polymerase formation to the same extent in both cell growth and minimal media. The greater percentage of inhibiton of polymerase preparations harvested at later times in the FMDV-polymerase kinetic cycle may be due to the longer time period that actinomycin D was present. Polymerase formation was also inhibited when actinomycin D was added as late as 150 min postinfection, when enzyme synthesis was already manifest. Data reported for the Mengovirus-Novikoff hepatoma cell system indicated that actinomycin D added after the production of viral polymerase had begun did not inhibit subsequent production of enzyme (17) .
The sucrose density profiles of RNA molecules produced in the cell-free RNA-synthesizing system were the same for polymerase isolated from cells infected in the presence or absence of actinomycin D. The inhibiting effect of actinomycin D on polymerase formation was, therefore, apparently on the whole replicating enzyme system and not on any one specific step. Actinomycin-treated Escherichia coli infected with the RNA bacteriophage MS2 has been reported to synthesize components not necessarily present in the infected, untreated cell (14) . The yield of infectious MS2 was also reduced. The apparent inhibition of infectious virus production by actinomycin D was more readily detectable when minimal medium was used as the incubating fluid rather than growth medium. This is consistent with the known decreased virus yields obtained from infected cells in the minimal medium (17) . The extra nutrients of cell growth medium are apparently able to counteract partially the actinomycin D inhibition of virus production, but are not able to prevent the decrease in polymerase formation. It has been reported that 1 ,ug of actinomycin D per ml has no effect on FMDV, type 0, multiplication in cloned BHK cells (6) , and preliminary experiments indicated that 5 
